# Topiramate in Adolescents With Severe Obesity

> **NCT01859013** · PHASE2 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 34 (actual)

## Conditions studied

- Obesity, Morbid
- Obesity
- Weight Loss

## Interventions

- **DRUG:** Topiramate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01859013
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2015-12
- **Final completion:** 2017-04
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01859013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01859013, "Topiramate in Adolescents With Severe Obesity". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01859013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*